Saylor's Orange Dots Go Silent Mode as StanChart Begs Him to Read the Room 📊

Strategy founder and chairman Michael Saylor posted a chart on Sunday captioned "Orange dots tell only part of the story," continuing a social media pattern that has typically preceded disclosures of Bitcoin purchases by the largest corporate holder of $BTC. Saylortracker.com data referenced in the post showed the company's holdings, though Strategy had earlier this month sold $216 million worth of Bitcoin, reducing its stash to 843,775 tokens according to a July 6 filing with the US Securities and Exchange Commission.

The sale marked a notable departure from Strategy's longstanding "never sell Bitcoin" posture. Days before the sale, the company unveiled a capital framework permitting Bitcoin sales to fund dividends, raised the annual dividend rate on its STRC preferred stock to 12%, and disclosed that its US dollar reserve had grown to $2.55 billion. Standard Chartered's global head of digital assets research, Geoff Kendrick, said in a Friday note to clients that Strategy's recent actions and Saylor's messaging "are muddying the waters for BTC near-term" and that clearer communication about the use of $BTC to back STRC is needed to reassure markets.

"We think effective communication of MSTR's new strategy (using BTC to back STRC) is key to reassuring markets that wholesale selling is unlikely; this should in turn support BTC prices," Kendrick wrote, adding that effective signalling could remove the need for MSTR to sell any Bitcoin by supporting STRC's price. He described the "never sell" approach as limiting because it constrains both what MSTR's $BTC holdings can do and what they are perceived to be doing, and noted that the company has shifted its communication strategy, sold $BTC twice, and announced a $BTC monetization program.

Kendrick said he expects Strategy's "market signaling" to improve and bring clarity to the outlook for Bitcoin, on which Standard Chartered maintains its $100,000 year-end forecast. The STRC preferred shares, formulated to hold a par value of $100 apiece, fell below that level last month, reflecting a difficult 12 months for investors who bought into the Strategy thesis ahead of the company's upcoming earnings report.